We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CAR T Cells: A Living Targeted Drug, With Dr Matt Cooper

Video   Mar 10, 2021

 

In this installment of Teach Me in 10, we're joined by Matt Cooper, co-founder and chief scientific officer at Wugen, Inc. He is also assistant professor of medicine at Washington University. Matt discusses what T cells are and how they can be engineered to recognize cancer cells.

This can be achieved by incorporating a specific receptor – the chimeric antigen receptor (CAR) – which results in the generation of CAR T cells.

“CAR T cells are essentially a living targeted drug,” – Matt Cooper.
Learn more about the key challenges related to engineering CAR T cells, discover ways to enable the broader application of these cells and hear about the development of allogeneic CAR T cells as an “off-the-shelf” treatment for cancer.

For more information on CAR T cells, check out:


Treating Cancer – 5 Types of Immunotherapy

Opinionated Science Episode 14: Cancer Immunotherapy: Vaccines, Viruses and Nobel Prizes

Cancer and the Immune System


Visit the Teach Me in 10 hub page for more < 10 minutes science!

 
More Information
 
 
Advertisement
 

Recommended Videos

Coronavirus Variants: What You Need To Know

Video

What do scientists mean when they talk about variants and what might this mean for the future of the pandemic?

WATCH NOW

Why Is the Gut Microbiome Important for Our Health?

Video

British Society for Immunology member and professor of immunology at Imperial College London Danny Altmann discusses what the gut microbiome is and why researchers think it could be important for helping our immune systems to function correctly.

WATCH NOW

Structural Biology Goes Viral With Dr Albert Konijnenberg

Video

What can integrative structural biology bring to viral research? That is the topic explored in this week's Teach Me in 10 at Technology Networks, featuring Dr Albert Konijnenberg.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE